What is she best known for?
The fields of study she is best known for:
- Gene
- Cancer
- Internal medicine
Her primary areas of study are Cancer research, Hepatocellular carcinoma, Adenoma, Hepatocellular adenoma and Mutation.
The various areas that Jessica Zucman-Rossi examines in her Cancer research study include Wnt signaling pathway, Carcinoma, CDKN2A and Gene mutation.
Her Hepatocellular carcinoma research is multidisciplinary, incorporating elements of Tumor suppressor gene, Hepatology, ARID1A and Somatic cell.
Her studies in Adenoma integrate themes in fields like Malignant transformation and Hepatocyte nuclear factors.
As part of one scientific family, Jessica Zucman-Rossi deals mainly with the area of Hepatocellular adenoma, narrowing it down to issues related to the Germline mutation, and often Benign tumor.
Her Mutation study results in a more complete grasp of Genetics.
Her most cited work include:
- Signatures of mutational processes in human cancer (5873 citations)
- Signatures of mutational processes in human cancer (5873 citations)
- Hepatocellular carcinoma. (1836 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Cancer research, Hepatocellular carcinoma, Internal medicine, Pathology and Hepatocellular adenoma.
The various areas that Jessica Zucman-Rossi examines in her Cancer research study include Carcinogenesis, Cancer, Tumor suppressor gene and Mutation, Gene mutation.
Her Hepatocellular carcinoma study incorporates themes from Carcinoma, Gene, Bioinformatics and Hepatitis B virus.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine.
Her research in Pathology intersects with topics in Cirrhosis and Focal nodular hyperplasia.
Her research integrates issues of Malignant transformation, HNF1A and Germline mutation in her study of Hepatocellular adenoma.
She most often published in these fields:
- Cancer research (57.11%)
- Hepatocellular carcinoma (38.14%)
- Internal medicine (27.42%)
What were the highlights of her more recent work (between 2017-2021)?
- Cancer research (57.11%)
- Hepatocellular carcinoma (38.14%)
- Internal medicine (27.42%)
In recent papers she was focusing on the following fields of study:
Her primary scientific interests are in Cancer research, Hepatocellular carcinoma, Internal medicine, Desk and Library science.
Jessica Zucman-Rossi is studying HCCS, which is a component of Cancer research.
Jessica Zucman-Rossi focuses mostly in the field of Hepatocellular carcinoma, narrowing it down to matters related to Hepatitis B and, in some cases, Viral hepatitis.
Jessica Zucman-Rossi has researched Internal medicine in several fields, including Gastroenterology and Oncology.
Her Oncology research incorporates themes from Proportional hazards model and Retrospective cohort study.
Her Carcinogenesis research integrates issues from Tumor microenvironment and Kinase.
Between 2017 and 2021, her most popular works were:
- Hepatocellular carcinoma. (1836 citations)
- cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. (133 citations)
- Molecular and histological correlations in liver cancer (84 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Jessica Zucman-Rossi spends much of her time researching Cancer research, Hepatocellular carcinoma, Internal medicine, Oncology and Liver cancer.
Jessica Zucman-Rossi studies Cancer research, namely HCCS.
The concepts of her Hepatocellular carcinoma study are interwoven with issues in Hepatitis B, Virology, Carcinoma and Gene expression profiling.
Her research investigates the connection with Internal medicine and areas like Gastroenterology which intersect with concerns in Cohort and Hepatocellular adenoma.
Her Oncology research incorporates elements of Tumor progression, Retrospective cohort study and Sorafenib.
Jessica Zucman-Rossi has included themes like Chronic liver disease, Gene mutation, Small hairpin RNA and Telomerase reverse transcriptase in her Liver cancer study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
